 | • レポートコード：MRC2312MG12121 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、83ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のゲパンツドラッグ市場規模と予測を収録しています。・世界のゲパンツドラッグ市場：売上、2018年-2023年、2024年-2029年 ・世界のゲパンツドラッグ市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のゲパンツドラッグ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リメゲパン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ゲパンツドラッグのグローバル主要企業は、PFIZER INC、 ABBVIE INCなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ゲパンツドラッグのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のゲパンツドラッグ市場：タイプ別、2018年-2023年、2024年-2029年 世界のゲパンツドラッグ市場：タイプ別市場シェア、2022年 ・リメゲパン、アトゲパン、ザベゲパン、ウブロゲパン 世界のゲパンツドラッグ市場：用途別、2018年-2023年、2024年-2029年 世界のゲパンツドラッグ市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界のゲパンツドラッグ市場：地域・国別、2018年-2023年、2024年-2029年 世界のゲパンツドラッグ市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるゲパンツドラッグのグローバル売上、2018年-2023年 ・主要企業におけるゲパンツドラッグのグローバル売上シェア、2022年 ・主要企業におけるゲパンツドラッグのグローバル販売量、2018年-2023年 ・主要企業におけるゲパンツドラッグのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 PFIZER INC、 ABBVIE INC ************************************************************* ・調査・分析レポートの概要 ゲパンツドラッグ市場の定義 市場セグメント 世界のゲパンツドラッグ市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のゲパンツドラッグ市場規模 世界のゲパンツドラッグ市場規模：2022年 VS 2029年 世界のゲパンツドラッグ市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのゲパンツドラッグの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のゲパンツドラッグ製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：リメゲパン、アトゲパン、ザベゲパン、ウブロゲパン ゲパンツドラッグのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 ゲパンツドラッグの用途別グローバル売上・予測 ・地域別市場分析 地域別ゲパンツドラッグ市場規模 2022年と2029年 地域別ゲパンツドラッグ売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） PFIZER INC、 ABBVIE INC ... |
This research report provides a comprehensive analysis of the Gepants Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Gepants Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Gepants Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Gepants Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Gepants Drugs market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Gepants Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Gepants Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Gepants Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Gepants Drugs market.
Market Overview: The report provides a comprehensive overview of the Gepants Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Rimegepant, Atogepant), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Gepants Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Gepants Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Gepants Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Gepants Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Gepants Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Gepants Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Gepants Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Gepants Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Gepants Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Rimegepant
Atogepant
Zavegepant
Ubrogepant
Market segment by Application
Hospital
Clinic
Other
Global Gepants Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
PFIZER INC
ABBVIE INC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gepants Drugs, market overview.
Chapter 2: Global Gepants Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gepants Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gepants Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gepants Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Gepants Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gepants Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gepants Drugs Overall Market Size
2.1 Global Gepants Drugs Market Size: 2022 VS 2029
2.2 Global Gepants Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gepants Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gepants Drugs Players in Global Market
3.2 Top Global Gepants Drugs Companies Ranked by Revenue
3.3 Global Gepants Drugs Revenue by Companies
3.4 Global Gepants Drugs Sales by Companies
3.5 Global Gepants Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gepants Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gepants Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gepants Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gepants Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gepants Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gepants Drugs Market Size Markets, 2022 & 2029
4.1.2 Rimegepant
4.1.3 Atogepant
4.1.4 Zavegepant
4.1.5 Ubrogepant
4.2 By Type – Global Gepants Drugs Revenue & Forecasts
4.2.1 By Type – Global Gepants Drugs Revenue, 2018-2023
4.2.2 By Type – Global Gepants Drugs Revenue, 2024-2029
4.2.3 By Type – Global Gepants Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Gepants Drugs Sales & Forecasts
4.3.1 By Type – Global Gepants Drugs Sales, 2018-2023
4.3.2 By Type – Global Gepants Drugs Sales, 2024-2029
4.3.3 By Type – Global Gepants Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Gepants Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gepants Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Gepants Drugs Revenue & Forecasts
5.2.1 By Application – Global Gepants Drugs Revenue, 2018-2023
5.2.2 By Application – Global Gepants Drugs Revenue, 2024-2029
5.2.3 By Application – Global Gepants Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Gepants Drugs Sales & Forecasts
5.3.1 By Application – Global Gepants Drugs Sales, 2018-2023
5.3.2 By Application – Global Gepants Drugs Sales, 2024-2029
5.3.3 By Application – Global Gepants Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Gepants Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gepants Drugs Market Size, 2022 & 2029
6.2 By Region – Global Gepants Drugs Revenue & Forecasts
6.2.1 By Region – Global Gepants Drugs Revenue, 2018-2023
6.2.2 By Region – Global Gepants Drugs Revenue, 2024-2029
6.2.3 By Region – Global Gepants Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Gepants Drugs Sales & Forecasts
6.3.1 By Region – Global Gepants Drugs Sales, 2018-2023
6.3.2 By Region – Global Gepants Drugs Sales, 2024-2029
6.3.3 By Region – Global Gepants Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gepants Drugs Revenue, 2018-2029
6.4.2 By Country – North America Gepants Drugs Sales, 2018-2029
6.4.3 US Gepants Drugs Market Size, 2018-2029
6.4.4 Canada Gepants Drugs Market Size, 2018-2029
6.4.5 Mexico Gepants Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gepants Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Gepants Drugs Sales, 2018-2029
6.5.3 Germany Gepants Drugs Market Size, 2018-2029
6.5.4 France Gepants Drugs Market Size, 2018-2029
6.5.5 U.K. Gepants Drugs Market Size, 2018-2029
6.5.6 Italy Gepants Drugs Market Size, 2018-2029
6.5.7 Russia Gepants Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gepants Drugs Market Size, 2018-2029
6.5.9 Benelux Gepants Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gepants Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Gepants Drugs Sales, 2018-2029
6.6.3 China Gepants Drugs Market Size, 2018-2029
6.6.4 Japan Gepants Drugs Market Size, 2018-2029
6.6.5 South Korea Gepants Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gepants Drugs Market Size, 2018-2029
6.6.7 India Gepants Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gepants Drugs Revenue, 2018-2029
6.7.2 By Country – South America Gepants Drugs Sales, 2018-2029
6.7.3 Brazil Gepants Drugs Market Size, 2018-2029
6.7.4 Argentina Gepants Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gepants Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gepants Drugs Sales, 2018-2029
6.8.3 Turkey Gepants Drugs Market Size, 2018-2029
6.8.4 Israel Gepants Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gepants Drugs Market Size, 2018-2029
6.8.6 UAE Gepants Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 PFIZER INC
7.1.1 PFIZER INC Company Summary
7.1.2 PFIZER INC Business Overview
7.1.3 PFIZER INC Gepants Drugs Major Product Offerings
7.1.4 PFIZER INC Gepants Drugs Sales and Revenue in Global (2018-2023)
7.1.5 PFIZER INC Key News & Latest Developments
7.2 ABBVIE INC
7.2.1 ABBVIE INC Company Summary
7.2.2 ABBVIE INC Business Overview
7.2.3 ABBVIE INC Gepants Drugs Major Product Offerings
7.2.4 ABBVIE INC Gepants Drugs Sales and Revenue in Global (2018-2023)
7.2.5 ABBVIE INC Key News & Latest Developments
8 Global Gepants Drugs Production Capacity, Analysis
8.1 Global Gepants Drugs Production Capacity, 2018-2029
8.2 Gepants Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gepants Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gepants Drugs Supply Chain Analysis
10.1 Gepants Drugs Industry Value Chain
10.2 Gepants Drugs Upstream Market
10.3 Gepants Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gepants Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
